Clinical Trial

Letrozole in Uterine Leiomyosarcoma

Name: Letrozole in Uterine Leiomyosarcoma — clinical trial record (NCT05649956)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This is a clinical trial to test letrozole in patients with uterine leiomyosarcoma. The main question is will treatment with letrozole extend progression-free survival in patients. Patients will receive 2/5 mg of letrozole daily.

Protocol Amendment History 1 change

minor Trial sites expanded: 25 -> 34 locations 2026-07-31

Trial Details

NCT Number	NCT05649956
Lead Sponsor	GOG Foundation
Conditions	Uterine Leiomyosarcoma
Enrollment	40 participants
Start Date	2024-07-17
Primary Completion	2028-07-30 (estimated)
Study Completion	2029-07-30 (estimated)
Updated on ClinicalTrials.gov	2026-07-30